- By FYH News Team
[ad_1]
However, his response leaves us more perplexed than enlightened. It is not clear whether Seytre is questioning the sources or disputing the facts. In any event, a careful reader of the US study we cited,
for example, will find therein explicit treatment of racism, medical abuse, and public trust (page 2 of the study). This finding has direct bearing on vaccine hesitancy and the history of colonial medicine and medical abuse in Africa, as shown by several studies (see Lowes and colleagues for a sample).
We certainly hope Seytre does not dispute the facts about global vaccine apartheid.
Comparing vaccine uptake for COVID-19 with that of diphtheria-tetanus-pertussis (DPT) is a false analogy. Vaccines for children have been widely accepted in Africa as a result of decades of investment in health workers and community engagement by governments and various partners, and the 80% coverage of DPT vaccines has been achieved by the WHO regional office over a long period of time. Additionally, and irrespective of knowledge, it is mandatory in most African countries for a child to be vaccinated to be enrolled in school.
It seems somewhat disingenuous that Seytre has referred to a dearth of knowledge in relation to his findings on risk perceptions, while castigating us for doing the same thing. This lapse, unwittingly, supports our conclusions. And if the whole point of Seytre’s response is that vaccine hesitancy can be addressed by communicating on the fact that COVID-19 is present in Africa, how the virus is transmitted, and who is at risk for the disease, we do not know how one could do so effectively without understanding and combatting fake news and misinformation, which was one of our four recommendations.
confirms our argument.
It is unfortunate that Seytre’s response generates more heat than light. Hair splitting and fault finding only distracts from attending to global vaccine apartheid and working towards global justice, which our Comment attempted to do.
We declare no competing interests.
References
- 1.
COVID-19 vaccine hesitancy in Africa: a call to action.
Lancet Glob Health. 2022; 10 (): e320-e321
- 2.
Researchers strive to recruit hard-hit minorities into COVID-19 vaccine trials.
JAMA. 2020; 324: 826-828
- 3.
The legacy of colonial medicine in central Africa.
Am Econ Rev. 2021; 111: 1284-1314
- 4.
The world is making billions of Covid vaccine doses, so why is Africa not getting them?.
- 5.
Vaccine hesitancy in Africa: causes and strategies to the rescue.
Ther Adv Vaccines Immunother. 2021; 9 ()
Article Info
Publication History
Identification
Copyright
© 2022 Published by Elsevier Ltd.
User License
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
ScienceDirect
Linked Articles
- COVID-19 vaccine hesitancy in Africa: a call to action
-
In addition to low COVID-19 vaccine coverage in Africa due to vaccine nationalism and vaccine diplomacy, the gradual effort to distribute COVID-19 vaccines to low-income and middle-income countries (LMICs) is threatened by vaccine hesitancy. In Africa in particular, the low vaccine coverage1 and the ubiquitous vaccine hesitancy in a concerning proportion of the population undermine efforts to fight the COVID-19 pandemic. We advocate for humane, culturally relevant, and rapid public health action to address these issues.
Full-Text
PDF
Open Access
-
- Misunderstanding poor adherence to COVID-19 vaccination in Africa
Open Access
[ad_2]
Source link
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
- Jessica Wilson
- Jessica Wilson
- Victor Mejia
